PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7519011-4	1994	Stimulation of dibutyryl cyclic AMP-differentiated HL-60 cells with the chemotactic peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP; 0.1 microM), the Ca(2+)-ATPase inhibitor thapsigargin (0.1 microM) or maitotoxin (25 ng/ml) resulted in an increase in cytoplasmic free calcium concentration ([Ca2+]i).	dibutyryl	15-24	formyl peptide receptor 1	Homo sapiens	139-143	
8842530-4	1996	We observed that the fMLP-induced phosphorylation of p47 phox, an essential component of neutrophil NADPH oxidase, was significantly attenuated in the presence of dibutyryl-cAMP or of receptor agonists of adenylate cyclase.	dibutyryl	163-172	formyl peptide receptor 1	Homo sapiens	21-25	
1651253-4	1991	Dibutyryl cAMP induced the expression of formyl peptide receptors and the responsiveness to fMLP.	dibutyryl	0-9	formyl peptide receptor 1	Homo sapiens	92-96	
1371803-8	1992	Dibutyryl cAMP at 0.2 mM reduced secretion in response to fMLP by 50% but did not inhibit TNF- and GM-CSF-induced degranulation.	dibutyryl	0-9	formyl peptide receptor 1	Homo sapiens	58-62	
8250850-2	1993	We compared G-protein activation by lipopeptides and the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine (fMLP) in dibutyryl-cyclic-AMP-differentiated HL-60 cells.	dibutyryl	126-135	formyl peptide receptor 1	Homo sapiens	117-121	
2544607-5	1989	Incubation of cells with dibutyryl cAMP inhibited this fMLP-stimulated granule-MT complex formation in a dose-responsive fashion.	dibutyryl	25-34	formyl peptide receptor 1	Homo sapiens	55-59